Tom Anderton

Tom Anderton is a highly accomplished legal professional with a rich background in intellectual property, biotech patent law, corporate law, and first amendment law.

He has held key positions at reputable organizations including K&L Gates, Zonare Medical Systems, Presidio Pharmaceuticals, Monogram Biosciences, Genencor International, and SUGEN.

Tom's expertise spans from building and managing IP portfolios to overseeing legal functions and developing patent strategies.

His educational background includes a J.D. from Vermont Law School, a B.S. in molecular biology from UC San Diego, and an M.S. in Cancer Biology from Stanford University School of Medicine.

Throughout his career, Tom has been recognized as one of the most influential IP practitioners in the United States, demonstrating his exceptional skills and knowledge in the field.

Specializing in biotech patent law, corporate and business law, and first amendment law, Tom Anderton continues to make significant contributions to the legal profession.

His experience in drafting and prosecuting patents, managing IP portfolios, and leading legal teams showcases his strategic mindset and legal acumen.

Tom is a registered member of the State Bar of California and possesses the eligibility to practice before the United States Patent and Trademark Office.